Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies

[1]  A. Kurilshikov,et al.  Environmental factors shaping the gut microbiome in a Dutch population , 2022, Nature.

[2]  Pieter B. T. Neerincx,et al.  Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project , 2022, Nature Genetics.

[3]  A. Kurilshikov,et al.  Challenges and future directions for studying effects of host genetics on the gut microbiome , 2022, Nature Genetics.

[4]  J. Rosmalen,et al.  Cohort Profile Update: Lifelines, a three-generation cohort study and biobank , 2021, International journal of epidemiology.

[5]  G. Abecasis,et al.  GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome , 2021, Cell genomics.

[6]  Wei Zhou,et al.  Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases , 2021, medRxiv.

[7]  M. Camilleri,et al.  Bile Acid Diarrhea in Adults and Adolescents , 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  D. Drossman,et al.  Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction (DGBI). , 2021, Gastroenterology.

[9]  Alicia R. Martin,et al.  Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps , 2021, Nature Medicine.

[10]  Laurent F. Thomas,et al.  Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders , 2021, Nature Genetics.

[11]  A. Franke,et al.  Adult sucrase-isomaltase deficiency masquerading as IBS , 2021, Gut.

[12]  Alicia R. Martin,et al.  Genome-wide association studies , 2021, Nature Reviews Methods Primers.

[13]  K. Kalari,et al.  Multi-omics analyses show disease, diet, and transcriptome interactions with the virome. , 2021, Gastroenterology.

[14]  M. D’Amato,et al.  Rare hypomorphic sucrase isomaltase variants in relation to IBS risk in UK Biobank. , 2021, Gastroenterology.

[15]  R. Spiller,et al.  The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome , 2021, Journal of cellular and molecular medicine.

[16]  N. Sousa,et al.  Sorting Out Sorting Nexins Functions in the Nervous System in Health and Disease , 2021, Molecular Neurobiology.

[17]  A. Kurilshikov,et al.  Role of the gut microbiome in mediating lactose intolerance symptoms , 2021, Gut.

[18]  M. Camilleri.  Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. , 2021, JAMA.

[19]  P. Visscher,et al.  GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression , 2021, Nature Communications.

[20]  M. Camilleri.  Gastrointestinal motility disorders in neurologic disease. , 2021, The Journal of clinical investigation.

[21]  Judy H. Cho,et al.  Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort. , 2020, Gastroenterology.

[22]  M. Neurath,et al.  All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective , 2020, ImmunoTargets and therapy.

[23]  V. Salomaa,et al.  Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort , 2020, Nature Genetics.

[24]  A. Hong,et al.  SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6. , 2020, Biochemical and biophysical research communications.

[25]  A. Regev,et al.  The Human and Mouse Enteric Nervous System at Single-Cell Resolution , 2020, Cell.

[26]  A. Peters,et al.  Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome , 2020, Nature Genetics.

[27]  Shiraz A. Shah,et al.  Large-scale association analyses identify host factors influencing human gut microbiome composition , 2020, Nature Genetics.

[28]  J. Raes,et al.  Genome-wide associations of human gut microbiome variation and implications for causal inference analyses , 2020, Nature Microbiology.

[29]  M. D’Amato,et al.  Hypomorphic SI genetic variants are associated with childhood chronic loose stools , 2020, PloS one.

[30]  M. Camilleri,et al.  Actionable biomarkers: the key to resolving disorders of gastrointestinal function , 2020, Gut.

[31]  M. Hoaglin,et al.  Gut microbiome composition and risk factors in a large cross-sectional IBS cohort , 2020, BMJ open gastroenterology.

[32]  P. Moayyedi,et al.  Evidence-based and mechanistic insights into exclusion diets for IBS , 2020, Nature Reviews Gastroenterology & Hepatology.

[33]  Padhmanand Sudhakar,et al.  Big data in IBD: big progress for clinical practice , 2020, Gut.

[34]  B. Tang.  Syntaxin 16’s Newly Deciphered Roles in Autophagy , 2019, Cells.

[35]  X. de la Cruz,et al.  PHF2 histone demethylase prevents DNA damage and genome instability by controlling cell cycle progression of neural progenitors , 2019, Proceedings of the National Academy of Sciences.

[36]  Christopher M. DeBoever,et al.  Assessing digital phenotyping to enhance genetic studies of human diseases , 2019, bioRxiv.

[37]  I. Hall,et al.  Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron , 2019, Alimentary pharmacology & therapeutics.

[38]  Aviv Regev,et al.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.

[39]  B. Ohlsson,et al.  A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients , 2019, Nutrients.

[40]  M. Surette,et al.  Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. , 2019, Gastroenterology.

[41]  Nicholas D. Youngblut,et al.  Human salivary amylase gene copy number impacts oral and gut microbiomes , 2018, bioRxiv.

[42]  Scott M. Williams,et al.  The Missing Diversity in Human Genetic Studies , 2019, Cell.

[43]  M. McCarthy,et al.  Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases , 2019, Nature Genetics.

[44]  W. Chey,et al.  Reduced efficacy of low FODMAPs diet in patients with IBS-D carrying sucrase-isomaltase (SI) hypomorphic variants , 2019, Gut.

[45]  O. Andreassen,et al.  A global overview of pleiotropy and genetic architecture in complex traits , 2019, Nature Genetics.

[46]  Morris A. Swertz,et al.  Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome , 2018, Science Translational Medicine.

[47]  M. Bonder,et al.  Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles , 2018, Gut microbes.

[48]  Nayoung Kim,et al.  Sex-Gender Differences in Irritable Bowel Syndrome , 2018, Journal of neurogastroenterology and motility.

[49]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[50]  Sumei Liu.  Neurotrophic factors in enteric physiology and pathophysiology , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[51]  H. Törnblom,et al.  Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem , 2018, The American Journal of Gastroenterology.

[52]  Day Fr,et al.  Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk , 2018, Yearbook of Paediatric Endocrinology.

[53]  A. Zhernakova,et al.  A GWAS meta‐analysis from 5 population‐based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[54]  Zachary F. Gerring,et al.  GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability , 2018, Nature Neuroscience.

[55]  A. Zhernakova,et al.  Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. , 2018, Gastroenterology.

[56]  J. Fins.  Family Portrait , 2018, Narrative inquiry in bioethics.

[57]  S. Cole,et al.  Radical and lunatic fringes modulate notch ligands to support mammalian intestinal homeostasis , 2018, eLife.

[58]  D. Tester,et al.  Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[59]  D. Posthuma,et al.  Item-level analyses reveal genetic heterogeneity in neuroticism , 2018, Nature Communications.

[60]  A. Zhernakova,et al.  The importance of cohort studies in the post-GWAS era , 2018, Nature Genetics.

[61]  A. Kurilshikov,et al.  Environment dominates over host genetics in shaping human gut microbiota , 2018, Nature.

[62]  W. Chey,et al.  Increased Prevalence of Rare Sucrase-isomaltase (SI) Pathogenic Variants in Irritable Bowel Syndrome Patients , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  Lin Chang,et al.  FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.

[64]  W. Lieb,et al.  Sucrase-isomaltase 15Phe IBS risk variant in relation to dietary carbohydrates and faecal microbiota composition , 2018, Gut.

[65]  J. Kaunitz,et al.  Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[66]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[67]  H. Dweep,et al.  miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome , 2017, Scientific Reports.

[68]  W. D. de Jonge,et al.  Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats. , 2017, Gastroenterology.

[69]  P. Dupont,et al.  Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome , 2017, Scientific Reports.

[70]  D. D. de Quervain,et al.  The NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals. , 2017, Journal of psychiatric research.

[71]  David Julius,et al.  Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways , 2017, Cell.

[72]  S. Slaugenhaupt,et al.  Familial dysautonomia: History, genotype, phenotype and translational research , 2017, Progress in Neurobiology.

[73]  Maristella,et al.  Genomic analyses identify hundreds of variants associated with age at menarche and 1 support a role for puberty timing in cancer risk 2 , 2017 .

[74]  M. Amiri,et al.  Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[75]  A. Auton,et al.  Replication and characterization of CADM2 and MSRA genes on human behavior , 2017, bioRxiv.

[76]  R. Carson,et al.  Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea , 2017, Health and Quality of Life Outcomes.

[77]  M. D’Amato,et al.  TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M , 2016, Gut.

[78]  M. Camilleri,et al.  Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome , 2016, Gut.

[79]  J. Christianson,et al.  Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[80]  Jessica L. Gören.  THE PHARMACODYNAMICS OF MEDICATIONS USED IN PSYCHIATRIC DISORDERS , 2016 .

[81]  A. Paterson,et al.  Association of host genome with intestinal microbial composition in a large healthy cohort , 2016, Nature Genetics.

[82]  J. Crispino,et al.  Novel function of FAXDC2 in megakaryopoiesis , 2016, Blood Cancer Journal.

[83]  M. Bonder,et al.  A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency , 2016, Gut.

[84]  N. Israsena,et al.  Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome , 2016, Journal of neurogastroenterology and motility.

[85]  David C. Wilson,et al.  Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.

[86]  Emily R. Davenport,et al.  Genetic Determinants of the Gut Microbiome in UK Twins. , 2016, Cell host & microbe.

[87]  D. Drossman,et al.  Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. , 2016, Gastroenterology.

[88]  D. Drossman.  Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. , 2016, Gastroenterology.

[89]  Morris A. Swertz,et al.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.

[90]  A. Franke,et al.  Stool frequency is associated with gut microbiota composition , 2016, Gut.

[91]  J. Sundquist,et al.  Familial risks of glomerulonephritis – a nationwide family study in Sweden , 2016, Annals of medicine.

[92]  Blair H. Smith,et al.  GWAS for executive function and processing speed suggests involvement of the CADM2 gene , 2016, Molecular Psychiatry.

[93]  M. Amiri,et al.  The multiple roles of sucrase-isomaltase in the intestinal physiology , 2016, Molecular and Cellular Pediatrics.

[94]  M. Bonder,et al.  Gut microbiota composition associated with stool consistency , 2015, Gut.

[95]  S. Brooks,et al.  Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented diet , 2015, Biology of Sex Differences.

[96]  B. Gomis.  A Multifaceted Problem , 2015 .

[97]  C. Wijmenga,et al.  Cohort Profile Cohort Profile : LifeLines , a three-generation cohort study and biobank , 2015 .

[98]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[99]  L. Öhman,et al.  Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome , 2015, Gut and liver.

[100]  R. Anney,et al.  Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci , 2015, European Journal of Human Genetics.

[101]  Y. Taché,et al.  Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia , 2015, Journal of neurogastroenterology and motility.

[102]  E. Stoeckli,et al.  The SynCAM synaptic cell adhesion molecules are involved in sensory axon pathfinding by regulating axon–axon contacts , 2014, Journal of Cell Science.

[103]  X. Zuo,et al.  Brain‐derived neurotrophic factor accelerates gut motility in slow‐transit constipation , 2014, Acta physiologica.

[104]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[105]  J. Kere,et al.  NPSR1 polymorphisms influence recurrent abdominal pain in children: a population‐based study , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[106]  K. Browning,et al.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. , 2014, Comprehensive Physiology.

[107]  S. Ward,et al.  Interstitial cells: regulators of smooth muscle function. , 2014, Physiological reviews.

[108]  W. Tourtellotte,et al.  A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation , 2014, Development.

[109]  M. Meleine,et al.  Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. , 2014, World journal of gastroenterology.

[110]  M. Gazouli,et al.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. , 2014, Gastroenterology.

[111]  R. Scott,et al.  Genome-Wide Association Study Identifies Two Novel Genomic Regions in Irritable Bowel Syndrome , 2014, The American Journal of Gastroenterology.

[112]  J. Koch,et al.  BAG-6, a jack of all trades in health and disease , 2014, Cellular and Molecular Life Sciences.

[113]  J. Sundquist,et al.  Risk of irritable bowel syndrome in first-degree, second-degree and thirddegree relatives of affected individuals: a nationwide family study in Sweden , 2014, Gut.

[114]  L. Avery,et al.  Gastrointestinal symptoms before and during menses in healthy women , 2014, BMC Women's Health.

[115]  Lei Shi.  Dock protein family in brain development and neurological disease , 2013, Communicative & integrative biology.

[116]  R. Khanna,et al.  Peppermint Oil for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis , 2013, Journal of clinical gastroenterology.

[117]  M. Daly,et al.  Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts , 2013, Gut.

[118]  B. Naliboff,et al.  Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[119]  M. D’Amato.  Genes and functional GI disorders: from casual to causal relationship , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[120]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[121]  T. Schwartz,et al.  GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. , 2013, Endocrinology.

[122]  H. Friess,et al.  Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity , 2013, Acta Neuropathologica.

[123]  P. Moayyedi,et al.  Peripheral mechanisms in irritable bowel syndrome. , 2013, The New England journal of medicine.

[124]  H. Kawahara,et al.  BAG6/BAT3: emerging roles in quality control for nascent polypeptides. , 2013, Journal of biochemistry.

[125]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[126]  A. Zinsmeister,et al.  Pharmacodynamic and Clinical Endpoints for Functional Colonic Disorders: Statistical Considerations , 2012, Digestive Diseases and Sciences.

[127]  Michael Camilleri,et al.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[128]  G. Breen,et al.  A Polymorphism Associated with Depressive Disorders Differentially Regulates Brain Derived Neurotrophic Factor Promoter IV Activity , 2012, Biological Psychiatry.

[129]  C. Wahlestedt,et al.  Natural Antisense Inhibition Results in Transcriptional De-Repression and Gene Upregulation , 2012, Nature biotechnology.

[130]  P. Visscher,et al.  Five years of GWAS discovery. , 2012, American journal of human genetics.

[131]  M. Heitkemper,et al.  Genetics and Gastrointestinal Symptoms , 2011, Annual Review of Nursing Research.

[132]  Sarah Edkins,et al.  Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.

[133]  J. Miquel,et al.  The European lactase persistence genotype determines the lactase persistence state and correlates with gastrointestinal symptoms in the Hispanic and Amerindian Chilean population: a case–control and population-based study , 2011, BMJ Open.

[134]  A. Zinsmeister,et al.  A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. , 2011, Gastroenterology.

[135]  J. Bueller,et al.  The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome. , 2011, Gastroenterology.

[136]  Yuri A Saito.  The role of genetics in IBS. , 2011, Gastroenterology clinics of North America.

[137]  G. Ast,et al.  IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia. , 2011, Human molecular genetics.

[138]  J. Tack,et al.  TRP channels in neurogastroenterology: opportunities for therapeutic intervention , 2011, British journal of pharmacology.

[139]  Christian Gieger,et al.  Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies , 2010, Nature Genetics.

[140]  Min Goo Lee,et al.  Syntaxin 16 Binds to Cystic Fibrosis Transmembrane Conductance Regulator and Regulates Its Membrane Trafficking in Epithelial Cells* , 2010, The Journal of Biological Chemistry.

[141]  P. Whorwell,et al.  5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex , 2010, European journal of gastroenterology & hepatology.

[142]  P. de Coppet,et al.  Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. , 2010, Gastroenterology.

[143]  P. Deloukas,et al.  Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.

[144]  L. Öhman,et al.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions , 2010, Nature Reviews Gastroenterology &Hepatology.

[145]  Li-Huei Tsai,et al.  Cyclin-dependent kinases: a family portrait , 2009, Nature Cell Biology.

[146]  A. Cole.  PCTK Proteins: The Forgotten Brain Kinases? , 2009, Neurosignals.

[147]  A. Baird,et al.  Estrogen and its role in gastrointestinal health and disease , 2009, International Journal of Colorectal Disease.

[148]  M. Camilleri.  Genetics and Irritable Bowel Syndrome: From Genomics to Intermediate Phenotype and Pharmacogenetics , 2009, Digestive Diseases and Sciences.

[149]  I. Kato,et al.  Expression of short-chain fatty acid receptor GPR41 in the human colon. , 2009, Biomedical research.

[150]  H. Katoh,et al.  Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons , 2009, Journal of neuroscience research.

[151]  Klaus-Peter Zimmer,et al.  Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase-isomaltase deficiency. , 2009, Gastroenterology.

[152]  Y. Taché,et al.  Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. , 2009, Annual review of physiology.

[153]  Takashi,et al.  RESOLUTION , 2009, Bring Now the Angels.

[154]  Cisca Wijmenga,et al.  Shared and distinct genetic variants in type 1 diabetes and celiac disease. , 2008, The New England journal of medicine.

[155]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[156]  P. Whorwell,et al.  First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. , 2008, Human molecular genetics.

[157]  P. Maness,et al.  L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth , 2008, Current Opinion in Neurobiology.

[158]  M. Camilleri,et al.  An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[159]  L. Kassem,et al.  Sequence variation in DOCK9 and heterogeneity in bipolar disorder , 2007, Psychiatric genetics.

[160]  C. Lindgren,et al.  Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. , 2007, Gastroenterology.

[161]  Y. Nie,et al.  The Association of Serotonin Transporter Genetic Polymorphisms and Irritable Bowel Syndrome and Its Influence on Tegaserod Treatment in Chinese Patients , 2007, Digestive Diseases and Sciences.

[162]  B. Bonaz,et al.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. , 2007, The Journal of clinical investigation.

[163]  I. Rooman,et al.  Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. , 2006, The American journal of pathology.

[164]  A. Zinsmeister,et al.  Gastrointestinal Symptoms in Families of Patients with an SCN5A-Encoded Cardiac Channelopathy: Evidence of an Intestinal Channelopathy , 2006, The American Journal of Gastroenterology.

[165]  J. Grider,et al.  Brain-derived neurotrophic factor augments peristalsis by augmenting 5-HT and calcitonin gene-related peptide release. , 2006, Gastroenterology.

[166]  D. Drossman,et al.  Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. , 2005, Gastroenterology clinics of North America.

[167]  L. Chang,et al.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome , 2005, Gut.

[168]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[169]  S. Moore,et al.  Acetylcholinesterase in Hirschsprung’s disease , 2005, Pediatric Surgery International.

[170]  M. Hongo,et al.  Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome , 2004, Gut.

[171]  A. Zinsmeister,et al.  Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders , 2004, Gut.

[172]  L. Olds,et al.  Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. , 2003, Human molecular genetics.

[173]  Lei Dong,et al.  Effects of neurotrophins on gastrointestinal myoelectric activities of rats. , 2003, World journal of gastroenterology.

[174]  M. Heitkemper,et al.  Impact of Sex and Gender on Irritable Bowel Syndrome , 2003, Biological research for nursing.

[175]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[176]  M. Camilleri,et al.  Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. , 2002, Gastroenterology.

[177]  W. Whitehead,et al.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? , 2002, Gastroenterology.

[178]  P. Whorwell,et al.  The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers , 2002, Gut.

[179]  M. Camilleri,et al.  Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome , 2001, American Journal of Gastroenterology.

[180]  H. Soreq,et al.  Acetylcholinesterase — new roles for an old actor , 2001, Nature Reviews Neuroscience.

[181]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[182]  M. Camilleri,et al.  Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. , 2000, Gastroenterology.

[183]  D. Drossman.  Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? , 1999, The American journal of medicine.

[184]  F. Gleeson,et al.  Onset of sucrase-isomaltase deficiency in late adulthood , 1999, American Journal of Gastroenterology.

[185]  M. Hongo,et al.  Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.

[186]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.

[187]  S. Phillips,et al.  How well does stool form reflect colonic transit? , 1996, Gut.

[188]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[189]  L. Belluscio,et al.  NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression , 1990, Neuron.

[190]  W. Whitehead,et al.  Evidence for exacerbation of irritable bowel syndrome during menses. , 1990, Gastroenterology.

[191]  Y. Taché,et al.  Central nervous system action of peptides to influence gastrointestinal motor function. , 1990, Gastroenterology.

[192]  G. Sturniolo,et al.  [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.

[193]  H. Preiser,et al.  Sucrase-isomaltase (palatinase) deficiency diagnosed during adulthood , 1980, Digestive Diseases and Sciences.

[194]  Adam L. Haber,et al.  Cellular and inter-cellular rewiring of the human colon during ulcerative colitis , 2019 .

[195]  A. Zinsmeister,et al.  Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. , 2010, Gastroenterology.

[196]  Hinrich W. H. Göhlmann,et al.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. , 2007, Gastroenterology.

[197]  M. Katoh,et al.  Notch signaling in gastrointestinal tract (review). , 2007, International journal of oncology.

[198]  Y. Taché,et al.  Central nervous system action of calcitonin to alter experimental gastric ulcers in rats. , 1988, Gastroenterology.

[199]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[200]  P Gangadharan,et al.  Statistical considerations. , 1973, Indian journal of cancer.